Search Results
Mar 30, 2026, 08:00 ET Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026
Randomized IDE study met all primary and secondary safety and efficacy endpoints and demonstrated superior debris capture and significantly higher technical success versus the leading embolic protection control device in TAVRSANTA
More news about: Emboline, Inc.
Mar 30, 2026, 06:00 ET IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma
trial evaluating IDE849 as a monotherapy and in combination with IDE161; the potential safety, tolerability, efficacy, and durability of IDE849 and IDE161; the potential therapeutic benefit and mechanism of action of IDE849, IDE161, and their combination; the potential of IDE849 and IDE161 to be first-in-class
More news about: IDEAYA Biosciences, Inc.
Mar 28, 2026, 23:26 ET 6. globálny summit inštalačných pracovníkov Huawei: Dávame dokopy najlepších inštalačných pracovníkov, aby sme využili príležitosti obnoviteľnej energie v ére AI
Huawei spolupracovať s partnermi a inštalačnými pracovníkmi s cieľom rásť, vytvárať hodnoty, nastavovať vysoké štandardy a spoločne víťaziť.Pokiaľ ide o firemnú kultúru a stratégie, Xia Hesheng, marketingový riaditeľ spoločnosti Huawei Digital Power, uviedol, že Huawei považuje za svoje hlavné poslanie
More news about: Huawei Digital Power
Mar 27, 2026, 08:09 ET Sonorous NV, Inc. Announces Leadership Transition
pulse-synchronous tinnitus due to venous sinus stenosis, enabling prioritized review and potential NTAP eligibility.Sonorous is advancing toward IDE submission and broader market approvals.Sonorous Neurovascular remains committed to developing minimally invasive solutions to improve quality
More news about: Sonorous NV, Inc.
Mar 26, 2026, 12:58 ET TCL predstavuje na veľtrhu MCE 2026 v Miláne riešenia klimatizácie s umelou inteligenciou
ponúkať aj vyhradené zážitkové zóny, kde si návštevníci môžu pozrieť jej najnovšie klimatizačné technológie predvádzané v reálnych situáciách. Ide napríklad o stabilný vykurovací výkon aj pri vonkajších teplotách až do -40 °C, ako aj pohodlné hlasové ovládanie prostredníctvom FreshIN 3.0.
More news about: TCL Europe
Mar 25, 2026, 08:30 ET Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
anticoagulant, anti-inflammatory and potential anti-viral activities. Niyad® is a lyophilized formulation of nafamostat and is currently being studied under an IDE, as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation Status from the FDA. Talphera's registrational
More news about: Talphera, Inc.
Mar 24, 2026, 10:36 ET Perforce 2026 State of Open Source Report Highlights Shift Toward Digital Autonomy in the EU
community of individuals and organizations with a business-friendly environment for open source software collaboration and innovation. We host the Eclipse IDE, Adoptium, Software Defined Vehicle, Jakarta EE, and over 425 open source projects, including runtimes, tools, specifications, and frameworks for cloud
More news about: Perforce Software
Mar 24, 2026, 10:07 ET Starlight Cardiovascular Announces First Baby in the World Treated with Lifeline Stent System at Cincinnati Children's Hospital
Disease.The Lifeline Ductus Arteriosus Stent System is an investigational device. Limited by Federal law to investigational use. Information concerning the IDE Study may be found on ClinicalTrials.gov, NCT07114718.
More news about: Starlight Cardiovascular
Mar 24, 2026, 08:01 ET Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
life-threatening viruses not addressed with approved therapies.The Hemopurifier is being developed under an open Investigational Device Exemption (IDE) for both indications.About Aethlon Medical, Inc.Aethlon Medical, Inc. (Nasdaq: AEMD) is a clinical stage medical device company
More news about: Aethlon Medical, Inc.
Mar 23, 2026, 08:30 ET Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
lead product candidate, Niyad® is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the U.S. Food and Drug Administration
More news about: Talphera, Inc.
Mar 22, 2026, 21:29 ET RyzoBee anuncia el lanzamiento de la serie Root en Kickstarter en el segundo trimestre de 2026
compatible con el desarrollo de Arduino: algunos proyectos oficiales publicarán código Arduino como código abierto y se proporcionará compatibilidad con el IDE de Arduino (las bibliotecas y los ejemplos se publicarán junto con el lanzamiento en Kickstarter).RyzoBee implementará soporte para la comunidad
More news about: RyzoBee
Mar 22, 2026, 21:27 ET RyzoBee kündigt geplanten Start der Root Series auf Kickstarter für das 2. Quartal 2026 an und bringt modulare RootMaker-Elektronik für Maker und 3D-Drucker-Kreative nach Nordamerika und Europa
Arduino-Entwicklung: Bei ausgewählten offiziellen Projekten wird der Arduino-Code als Open Source veröffentlicht, und es wird Unterstützung für die Arduino-IDE angeboten (Bibliotheken und Beispiele werden zeitgleich zum Kickstarter-Launch veröffentlicht).RyzoBee wird den Community- und Content-Support
More news about: RyzoBee
Mar 22, 2026, 21:25 ET RyzoBee annonce le lancement sur Kickstarter de sa série Root prévue pour le deuxième trimestre 2026, apportant l'électronique modulaire RootMaker aux fabricants et aux créateurs d'impression 3D en Amérique du Nord et en Europe
en charge le développement Arduino : les projets officiels sélectionnés publieront le code Arduino en tant que source ouverte, et le support Arduino IDE sera fourni (les bibliothèques et les exemples seront publiés en même temps que le lancement de Kickstarter).RyzoBee mettra en place une assistance
More news about: RyzoBee
Mar 21, 2026, 10:15 ET RyzoBee Announces Root Series Kickstarter Launch Planned for Q2 2026, Bringing Modular RootMaker Electronics to Makers and 3D Printing Creators in North America and Europe
customize from there. The platform also supports Arduino development: selected official projects will release Arduino code as open source, and Arduino IDE support will be provided (libraries and examples will be released alongside the Kickstarter launch).RyzoBee will roll out community and content
More news about: RyzoBee
Mar 21, 2026, 10:15 ET RyzoBee Announces Root Series Kickstarter Launch Planned for Q2 2026, Bringing Modular RootMaker Electronics to Makers and 3D Printing Creators in North America and Europe
customize from there. The platform also supports Arduino development: selected official projects will release Arduino code as open source, and Arduino IDE support will be provided (libraries and examples will be released alongside the Kickstarter launch).RyzoBee will roll out community and content
More news about: RyzoBee
Mar 20, 2026, 18:03 ET Fractal EMS získava certifikácie ISO/IEC 9001 a 27001
batériových úložísk, solárnych a hybridných systémov a dátových centier, oznámila úspešné udelenie certifikácií ISO 9001:2015 a ISO/IEC 27001:2022. Ide o medzinárodne uznávané normy pre systémy riadenia kvality (QMS) a systémy riadenia informačnej bezpečnosti (ISMS). Tento významný míľnik potvrdzuje
More news about: Fractal EMS Inc.
Mar 20, 2026, 08:10 ET DCK predstavuje na veľtrhu EISENWARENMESSE 2026 rozšírené portfólio profesionálneho elektrického náradia a exteriérového elektrického vybavenia - posilnenie angažovanosti na európskom trhu
distribútormi, partnermi a profesionálnymi používateľmi v celom regióne. Od profesionálnych používateľov získala silnú pozitívnu spätnú väzbu, najmä pokiaľ ide o vysoký výkon produktov, dlhotrvajúcu odolnosť, kompatibilitu batérií na rôznych platformách a ergonomický dizajn. Prostredníctvom tohto zapojenia spoločnosť
More news about: DongCheng
Mar 19, 2026, 10:07 ET Endovascular Engineering Announces Dual Late-Breaking Presentations at SIR and SCAI 2026 Highlighting Validation of Blood Return and Comprehensive ENGULF Study Results
outcomes. Each presentation showcases distinct, complementary datasets from the ENGULF IDE study. This represents one of the most comprehensive evidence packages presented for a mechanical thrombectomy system IDE study to date.The SIR presentation by Dr. Julie C. Bulman, ENGULF National Co-Principal
More news about: Endovascular Engineering, Inc.
Mar 19, 2026, 09:00 ET Boost Security Launches Developer Endpoint Security to Secure AI-Driven Software Development at the Source
are dramatically increasing developer productivity, but they are also introducing new security risks. Developers are installing plugins, MCP servers, IDE extensions, and packages recommended by AI agents while credentials accumulate across configuration files, environment variables, and local machines.
More news about: Boost Security
Mar 19, 2026, 09:00 ET Aikido Receives the 2026 Global Application Security Posture Management Customer Value Leadership Recognition for Excellence in Developer-First Security Innovation
runtime, replacing fragmented tools with a single, cost-effective solution. By embedding automated checks early in integrated development environments (IDE) and CI/CD pipelines, Aikido reduces operational friction and accelerates remediation. The platform's AI-powered capabilities support autonomous discovery
More news about: Frost & Sullivan
Mar 19, 2026, 09:00 ET Aikido Receives the 2026 Global Application Security Posture Management Customer Value Leadership Recognition for Excellence in Developer-First Security Innovation
runtime, replacing fragmented tools with a single, cost-effective solution. By embedding automated checks early in integrated development environments (IDE) and CI/CD pipelines, Aikido reduces operational friction and accelerates remediation. The platform's AI-powered capabilities support autonomous discovery
More news about: Frost & Sullivan
Mar 19, 2026, 09:00 ET Astronomer EMEA Momentum Building with 122% ARR Growth
Discover the Astro IDE to ship pipelines 10x faster
More news about: Astronomer
Mar 18, 2026, 16:05 ET Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
anti-inflammatory and potential anti-viral activities. Niyad® is a lyophilized formulation of nafamostat and is currently being studied under an IDE, as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation Status from the FDA. Talphera's registrational
More news about: Talphera, Inc.
Mar 18, 2026, 06:00 ET IDEAYA Biosciences Announces Upcoming Presentations at AACR 2026 Highlighting Multiple Clinical Stage Pipeline Programs
first-in-class programs from IDEAYA's clinical stage pipeline: IDE034, a PTK7/B7H3 bi-specific topoisomerase-1 (TOP1) antibody-drug conjugate (ADC); IDE574, a potent dual inhibitor of the lysine acetyltransferase (KAT) 6 and 7; and IDE892, an MTA-cooperative inhibitor of PRMT5. The company is currently
More news about: IDEAYA Biosciences, Inc.
Mar 17, 2026, 08:29 ET ActiveState Launches Curated Catalogs to Neutralize Security Risks in AI-Generated Code
trusted catalog of more than 79 million secure open source components and container images that can be consumed via artifact repository, CI/CD platform, IDE, or directly from ActiveState. ActiveState continuously monitors and updates the open source components to help keep companies vulnerability free. Companies
More news about: ActiveState